CP Reports Store
Current Partnering is the market-leading publisher of pharmaceutical and biotechnology dealmaking intelligence reports covering licensing agreements, collaboration agreements, co-development deals, M&A transactions, strategic alliances and partnering activity across the life sciences industry.
Our reports provide detailed analysis of real-world deal structures and financial terms, including upfront payments, milestone payments, royalty rates, equity investments and option-based deal mechanisms. Drawing on thousands of disclosed agreements, the reports enable business development and licensing professionals to benchmark comparable transactions and understand how partnerships are structured across therapeutic areas, technologies and company types.
Beyond financial terms, Current Partnering tracks key contractual provisions including exclusivity arrangements, geographic and territorial rights, regional licensing structures, development and commercialization responsibilities, co-promotion rights, manufacturing rights, intellectual property provisions and rights allocation between partners. This enables users to evaluate not only deal value but also how strategic control, risk and commercial opportunity are distributed between parties.
Coverage spans a broad range of therapeutic areas and technologies, including oncology, immunology, rare diseases, cell therapy, gene therapy, antibody-drug conjugates (ADCs), RNA therapeutics, vaccines and precision medicine.
Reports are widely relied upon globally by business development, licensing, corporate strategy, competitive intelligence and executive leadership teams to identify partners, benchmark transactions and support dealmaking decisions with real-world market evidence.
Browse our deal reports by: Deal Structure | Therapy | Technology | Development Stage | Industry | Annual Subscriptions
-
Gynecology Collaboration and Licensing Deals 2016-2026October 2026$3,995.00155 gynecology partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication and target analysis | Contract intelligence
Learn More -
Animal Health Partnering Terms and Agreements 2017 to 2026October 2026$3,995.00294 animal health partnerships | Deal structures and financial benchmarks | Leading dealmakers and prospective partners | Disease and technology analysis | Contract intelligence
Learn More -
Academic and Non-Profit Partnering Terms and Agreements 2021-2026October 2026$4,995.002,448 academic and non-profit partnerships | Deal structures and financial benchmarks | Leading institutions and industry partners | Technology and therapy analysis | Contract intelligence
Learn More -
Generic Pharmaceutical Partnering Terms and Agreements 2010-2026October 2026$3,995.00Global Generic Pharmaceutical Partnering Terms and Agreements 2010 to 2026 report provides a detailed understanding and analysis of how and why companies enter generic pharmaceutical partnering deals.
Learn More -
Specialty Pharmaceutical Partnering Terms and Agreements 2020-2026October 2026$3,995.001,019 specialty pharmaceutical partnerships | Deal structures and financial benchmarks | Leading dealmakers and prospective partners | Therapy and technology analysis | Contract intelligence
Learn More -
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology 2016-2026September 2026$3,995.00Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2026
Learn More -
Distribution Deals in Pharmaceuticals and Biotechnology 2020 to 2026September 2026$3,995.00Distribution Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2026
Learn More -
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2021-2026September 2026$4,995.00Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory
Learn More -
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019 to 2026September 2026$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2026
Learn More -
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2026September 2026$4,995.00Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory
Learn More
